Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests in Consolidated Subsidiaries	Total
Balance at beginning of period at Dec. 31, 2018	$ 1,210	$ 3,155,256	$ (176,018)	$ 6,700	$ 204	$ 2,987,352
Balance at beginning of period (in shares) at Dec. 31, 2018	120,937
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to common shareholders and noncontrolling interests			65,571			65,571
Common shares issued	$ 115	472,665				472,780
Common shares issued (in shares)	11,500
Conversion of common limited partnership units to common shares	$ 17	57,301				57,318
Conversion of common limited partnership units to common shares (in shares)	1,664
Common shares issued pursuant to Employee Share Purchase Plan ("ESPP")		1,803				1,803
Common shares issued pursuant to Employee Share Purchase Plan ("ESPP") ( in shares)	47
Dividends declared on common shares			(120,717)			(120,717)
Distributions to noncontrolling interests					(3)	(3)
Redeemable noncontrolling interests redemption value adjustment and other comprehensive loss allocation		(53,983)		2,584		(51,399)
Other comprehensive income (loss)				(26,028)		(26,028)
Balance at end of period (in shares) at Dec. 31, 2019	134,148
Balance at end of period at Dec. 31, 2019	$ 1,342	3,633,042	(231,164)	(16,744)	201	3,386,677
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to common shareholders and noncontrolling interests			(62,303)			(62,303)
Conversion of common limited partnership units to common shares	$ 13	47,504				47,517
Conversion of common limited partnership units to common shares (in shares)	1,338
Common shares repurchased	$ (37)	(104,737)				(104,774)
Common shares repurchased (in shares)	(3,776)
Common shares issued pursuant to Employee Share Purchase Plan ("ESPP")	$ 1	2,241				2,242
Common shares issued pursuant to Employee Share Purchase Plan ("ESPP") ( in shares)	68
Dividends declared on common shares			(119,477)			(119,477)
Distributions to noncontrolling interests					(34)	(34)
Redeemable noncontrolling interests redemption value adjustment and other comprehensive loss allocation		79,593		2,990		82,583
Other comprehensive income (loss)				(26,225)		$ (26,225)
Balance at end of period (in shares) at Dec. 31, 2020	131,778					131,778
Balance at end of period at Dec. 31, 2020	$ 1,319	3,657,643	(412,944)	(39,979)	167	$ 3,206,206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to common shareholders and noncontrolling interests			(79,257)		(1,740)	(80,997)
Conversion of common limited partnership units to common shares	$ 9	29,625				29,634
Conversion of common limited partnership units to common shares (in shares)	906
Common shares repurchased	$ (54)	(157,632)				(157,686)
Common shares repurchased (in shares)	(5,370)
Common shares issued pursuant to employee incentive compensation plan and ESPP	$ 1	2,426				2,427
Common shares issued pursuant to employee incentive compensation plan and ESPP (in shares)	64
Dividends declared on common shares			(117,130)			(117,130)
Contributions from noncontrolling interests, net					24,080	24,080
Redeemable noncontrolling interests redemption value adjustment and other comprehensive loss allocation		7,854		(2,675)		5,179
Other comprehensive income (loss)				26,704		$ 26,704
Balance at end of period (in shares) at Dec. 31, 2021	127,378					127,378
Balance at end of period at Dec. 31, 2021	$ 1,275	$ 3,539,916	$ (609,331)	$ (15,950)	$ 22,507	$ 2,938,417